Epocal has received FDA approval for its point-of-care blood analysis system, Epoc. Epoc rapidly performs a panel of the most critical acute care tests at the patient's bedside. The device measures pH, PaCO₂, PaO₂, sodium potassium, ionized calcium, and hematocrit and calculates HCO₃, total CO₂, base excess, SaO₂, and hemoglobin.

This user-friendly and cost-effective system includes blood test cards on the company's proprietary adaptation of smart card technology and low-cost card readers that are wirelessly connected to handheld PDAs (the host computer).

The complete test record is available through the host computer interface and is wirelessly transmissible for further reporting, analysis, and data archiving.

Source